• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用稳定性指示性尺寸排阻高效液相色谱法评估聚乙二醇化和糖基化对促红细胞生成素稳定性的联合影响。

Evaluation of the combined effects of pegylation and glycosylation on the stability of erythropoietin using a stability-indicating SE-HPLC.

作者信息

Abed Heba S, Al-Ghobashy Medhat A, Fathalla Faten A, Salem Maissa Y

机构信息

National Organization for Research and Control of Biologicals, Egypt.

Analytical Chemistry Department, Faculty of Pharmacy, Cairo University, Egypt; Bioanalysis Research Group, School of Pharmacy, New Giza University, Egypt.

出版信息

Biologicals. 2017 Nov;50:129-136. doi: 10.1016/j.biologicals.2017.08.012. Epub 2017 Sep 27.

DOI:10.1016/j.biologicals.2017.08.012
PMID:28958787
Abstract

Recombinant human erythropoietin (rhEPO) is a commonly used biopharmaceutical for the treatment of anemia-associated disorders. Epogen; glycosylated erythropoietin (G-EPO) has short half-life and poor stability. Pegylated Epogen (Peg-G-EPO) was introduced to the market to overcome these limitations. The combined effects of pegylation and glycosylation on the stability of Peg-G-EPO was studied. Determination of Peg-G-EPO in the presence of its degradation products was achieved using SE-HPLC. The assay was validated according to ICH guidelines over concentration range of 50.00-320.00 μg/mL (r 0.9999). A mobile phase of 50 mM phosphate buffer (pH 6.5) with 300 mM sodium chloride and 20% ethanol was employed. Isocratic elution was carried out at 0.5 mL/min over run time of 30 min. Peg-G-EPO was found stable towards mechanical agitation only at low concentrations while it was stable towards repeated freeze/thaw; regardless of the concentration. Effect of temperature and pH were also investigated and Peg-G-EPO was found stable within narrow ranges. Results indicated formation of small molecular weight and very high molecular weight aggregates that have been filtered-off the column. Although Peg-G-EPO was found relatively more stable than its non-pegylated but glycosylated version, results indicated the need for careful stability-assessment of Peg-G-EPO.

摘要

重组人促红细胞生成素(rhEPO)是一种常用于治疗贫血相关疾病的生物制药。促红细胞生成素;糖基化促红细胞生成素(G-EPO)半衰期短且稳定性差。聚乙二醇化促红细胞生成素(Peg-G-EPO)被引入市场以克服这些局限性。研究了聚乙二醇化和糖基化对Peg-G-EPO稳定性的综合影响。使用尺寸排阻高效液相色谱法(SE-HPLC)在其降解产物存在的情况下测定Peg-G-EPO。该测定法在50.00 - 320.00μg/mL的浓度范围内根据国际人用药品注册技术协调会(ICH)指南进行了验证(r = 0.9999)。采用含有300 mM氯化钠和20%乙醇的50 mM磷酸盐缓冲液(pH 6.5)作为流动相。在30分钟的运行时间内以0.5 mL/分钟的流速进行等度洗脱。发现Peg-G-EPO仅在低浓度下对机械搅拌稳定,而对反复冻融稳定,无论浓度如何。还研究了温度和pH的影响,发现Peg-G-EPO在较窄的范围内稳定。结果表明形成了已从柱中滤出的小分子和非常高分子量的聚集体。尽管发现Peg-G-EPO比其未聚乙二醇化但糖基化的版本相对更稳定,但结果表明需要对Peg-G-EPO进行仔细的稳定性评估。

相似文献

1
Evaluation of the combined effects of pegylation and glycosylation on the stability of erythropoietin using a stability-indicating SE-HPLC.使用稳定性指示性尺寸排阻高效液相色谱法评估聚乙二醇化和糖基化对促红细胞生成素稳定性的联合影响。
Biologicals. 2017 Nov;50:129-136. doi: 10.1016/j.biologicals.2017.08.012. Epub 2017 Sep 27.
2
Correlation between Dynamic Light Scattering and Size Exclusion High Performance Liquid Chromatography for Monitoring the Effect of pH on Stability of Biopharmaceuticals.动态光散射与尺寸排阻高效液相色谱法之间的相关性用于监测pH对生物制药稳定性的影响
J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Aug 15;1060:1-9. doi: 10.1016/j.jchromb.2017.05.029. Epub 2017 May 26.
3
Comparative Assessment of the Effect of Hyper-glycosylation on the Pattern and Kinetics of Degradation of Darbepoetin Alfa using a Stability-Indicating Orthogonal Testing Protocol.使用稳定性指示正交试验方案对高糖基化对达贝泊汀α降解模式和动力学的影响进行比较评估。
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Jan 1;1072:405-414. doi: 10.1016/j.jchromb.2017.10.057. Epub 2017 Nov 4.
4
Design, modeling, expression, and chemoselective PEGylation of a new nanosize cysteine analog of erythropoietin.新型纳米半胱氨酸模拟促红细胞生成素的设计、建模、表达和化学选择性聚乙二醇化。
Int J Nanomedicine. 2011;6:1217-27. doi: 10.2147/IJN.S19081. Epub 2011 Jun 15.
5
The impact of sialic acids on the pharmacokinetics of a PEGylated erythropoietin.唾液酸对聚乙二醇化红细胞生成素药代动力学的影响。
J Pharm Sci. 2012 Dec;101(12):4414-8. doi: 10.1002/jps.23320. Epub 2012 Sep 16.
6
Stabilization of bacterially expressed erythropoietin by single site-specific introduction of short branched PEG chains at naturally occurring glycosylation sites.通过在天然存在的糖基化位点单一位点特异性引入短支链聚乙二醇链来稳定细菌表达的促红细胞生成素。
Mol Biosyst. 2016 May 24;12(6):1750-5. doi: 10.1039/c5mb00857c.
7
PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: a comparison with glycosylated erythropoietin.聚乙二醇化显著增强了重组人非糖基化红细胞生成素的体内效力:与糖基化红细胞生成素的比较。
J Control Release. 2010 Aug 3;145(3):306-13. doi: 10.1016/j.jconrel.2010.04.021. Epub 2010 Apr 26.
8
Efficient preparation and PEGylation of recombinant human non-glycosylated erythropoietin expressed as inclusion body in E. coli.高效制备和聚乙二醇化重组人非糖基化红细胞生成素,该蛋白在大肠杆菌中以包涵体形式表达。
Int J Pharm. 2010 Feb 15;386(1-2):156-64. doi: 10.1016/j.ijpharm.2009.11.016. Epub 2009 Nov 20.
9
Computational and nonglycosylated systems: a simpler approach for development of nanosized PEGylated proteins.计算和非糖基化系统:一种开发纳米级聚乙二醇化蛋白质的更简单方法。
Drug Des Devel Ther. 2016 Mar 16;10:1193-200. doi: 10.2147/DDDT.S98323. eCollection 2016.
10
Improving the recombinant human erythropoietin glycosylation using microsome supplementation in CHO cell-free system.利用 CHO 无细胞体系中的微粒体补充物改善重组人促红细胞生成素的糖基化。
Biotechnol Bioeng. 2018 May;115(5):1253-1264. doi: 10.1002/bit.26554. Epub 2018 Feb 13.

引用本文的文献

1
PEGylated Erythropoietin Protects against Brain Injury in the MCAO-Induced Stroke Model by Blocking NF-κB Activation.聚乙二醇化促红细胞生成素通过阻断核因子κB激活在大脑中动脉闭塞诱导的中风模型中预防脑损伤。
Biomol Ther (Seoul). 2020 Mar 1;28(2):152-162. doi: 10.4062/biomolther.2019.147.